CSIR-CCMB develops India-specific tool to predict sickle cell severity
Scientists at the CSIR-Centre for Cellular and Molecular Biology have developed a new tool to predict the severity of sickle cell anaemia specifically for Indian patients. This tool aims to improve treatment outcomes by accounting for clinical differences between Indian patients and those in Western or African populations.
Why it matters
Sickle cell anaemia is a major health burden in India, and localized diagnostic tools can significantly improve patient management and reduce mortality.
Doctors may soon have a more reliable way to predict how severely sickle cell anaemia (SCA) will affect Indian patients, thanks to a new India-specific disease severity score developed by scientists at the CSIR-Centre for Cellular and Molecular Biology (CCMB).
The new tool, developed using clinical data from Indian children, could improve treatment decisions and disease management as existing international scoring systems do not accurately reflect the clinical profile of Indian patients with SCA, whose disease patterns often differ from those seen in African and Western populations.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in